Literature DB >> 25726650

[Comparative study on substituting hedyseri radix for astragali radix in serum containing yiqiyangxue prescription on aged mice spleen lymphocyte proliferation and anti-oxidant effect].

Guang Yang, Wei-Dong Cheng, Li-Feng Zhang, Wen-Ting Xing, Yi-Yan Zhou, Xiao-Fen Sun.   

Abstract

OBJECTIVE: By substituting Hedyseri Radix for Astragali Radix in Yiqiyangxue prescription, to compare the effects of both serum containing medicine on aged mice spleen lymphocyte proliferation and anti-oxidant effect.
METHOD: After using the same dose of Hedyseri Radix to replace Astragali Radix in Yiqiyangxue prescription, the best concentration of serum containing medicine,the best incubation time and the effects of ConA-induced spleen lymphocyte proliferation were determined by MTY method. Use reagent kits to detect the activity of SOD, MDA and ROS levels in aged mice spleen lymphocytes and IL-2 level in culture supernatant fluid of spleen lymphocytes.
RESULTS: Both serum containing medicine can enhance the proliferation of aged mice spleen lymphocytes. The best concentration of serum containing medicine was 40% and the incubation time was 72 h. The serum containing Yiqiyangxue of Hedyseri Radix prescription acted more effective than that of Astragali Radix on the enhancement of proliferation. Both serum containing medicine showed similar effects on increasing SOD activity, IL-2 level and decreasing MDA and ROS level. Moreover,serum of Hedyseri Radix was superior in the enhancement of proliferation, IL-2 and the reduction of ROS level.
CONCLUSION: Both serum containing medicine of Hedyseri Radix and Astragali Radix generate the same effect of anti-aging and enhancement of proliferation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25726650

Source DB:  PubMed          Journal:  Zhong Yao Cai        ISSN: 1001-4454


  1 in total

1.  Anti-Inflammatory Effects of Modified Buyang Huanwu Decoction.

Authors:  Hyang-Hwa Ryu; Jun-Chul Kang; Uk Namgung; Song-Yi Kim; Ji-Yeun Park
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-13       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.